Huirong Huang

725 total citations · 1 hit paper
23 papers, 550 citations indexed

About

Huirong Huang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Huirong Huang has authored 23 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Rheumatology. Recurrent topics in Huirong Huang's work include Osteoarthritis Treatment and Mechanisms (5 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Bone and Joint Diseases (3 papers). Huirong Huang is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Bone and Joint Diseases (3 papers). Huirong Huang collaborates with scholars based in China, United States and New Zealand. Huirong Huang's co-authors include Ruijie Chen, Longfa Kou, Qing Yao, Xinyu Jiang, Daosen Chen, Meng Sun, Shihui Bao, Rui Sun, Chao Li and Hailun Zheng and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release and Advanced Science.

In The Last Decade

Huirong Huang

23 papers receiving 549 citations

Hit Papers

Metabolic reprogramming of macrophages by a nano-sized op... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Metabolic reprogramming of macrophages by a nano-sized opsonization strategy to restore M1/M2 balance for osteoarthritis therapy
    2025 19 citations Ruijie Chen, Huirong Huang et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huirong Huang China 14 211 140 97 81 72 23 550
Huiming Jiang China 17 266 1.3× 119 0.8× 150 1.5× 86 1.1× 45 0.6× 36 746
Kan Chen China 18 226 1.1× 159 1.1× 80 0.8× 36 0.4× 148 2.1× 36 912
Yingying Tan China 12 316 1.5× 49 0.3× 99 1.0× 43 0.5× 99 1.4× 32 607
Qingmin Zeng China 16 274 1.3× 43 0.3× 79 0.8× 69 0.9× 113 1.6× 49 665
Deming Xiao China 11 345 1.6× 115 0.8× 106 1.1× 42 0.5× 59 0.8× 23 711
Sheng Lü China 16 324 1.5× 45 0.3× 178 1.8× 54 0.7× 115 1.6× 36 685
Xiaochen Liu China 15 285 1.4× 36 0.3× 116 1.2× 57 0.7× 100 1.4× 25 686
Sheji Weng China 15 272 1.3× 41 0.3× 110 1.1× 28 0.3× 76 1.1× 23 566

Countries citing papers authored by Huirong Huang

Since Specialization
Citations

This map shows the geographic impact of Huirong Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huirong Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huirong Huang more than expected).

Fields of papers citing papers by Huirong Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huirong Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huirong Huang. The network helps show where Huirong Huang may publish in the future.

Co-authorship network of co-authors of Huirong Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Huirong Huang. A scholar is included among the top collaborators of Huirong Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huirong Huang. Huirong Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ruijie, Huirong Huang, Chenyu Qiu, et al.. (2025). Metabolic reprogramming of macrophages by a nano-sized opsonization strategy to restore M1/M2 balance for osteoarthritis therapy. Journal of Controlled Release. 380. 469–489. 19 indexed citations breakdown →
2.
Chen, Zhiwei, Sibo Zhu, Lei Cai, et al.. (2025). Inflammation-targeted nanoparticles modulate macrophage polarization for coronary therapy in Kawasaki disease. Journal of Controlled Release. 388(Pt 2). 114350–114350. 1 indexed citations
3.
Huang, Huirong, Shengjie Li, Pengfei Mao, et al.. (2024). Opsonization Inveigles Macrophages Engulfing Carrier‐Free Bilirubin/JPH203 Nanoparticles to Suppress Inflammation for Osteoarthritis Therapy. Advanced Science. 11(22). e2400713–e2400713. 36 indexed citations
4.
Huang, Huirong, Shengjie Li, Yuqi Yan, et al.. (2024). Chondrocyte-targeted bilirubin/rapamycin carrier-free nanoparticles alleviate oxidative stress and modulate autophagy for osteoarthritis therapy. Journal of Controlled Release. 378. 517–533. 13 indexed citations
5.
Huang, Huirong, Xinyu Jiang, Chenyu Qiu, et al.. (2024). Supramolecular nanoparticle loaded with bilirubin enhances cartilage protection and alleviates osteoarthritis via modulating oxidative stress and inflammatory responses. Colloids and Surfaces B Biointerfaces. 245. 114243–114243. 5 indexed citations
6.
Huang, Huirong, Meng Sun, Shengjie Li, et al.. (2024). Enhancing retention and permeation of rapamycin for osteoarthritis therapy using a two-stage drug delivery system. Materials Today Bio. 29. 101279–101279. 4 indexed citations
7.
Dai, Sheng, Jie Ding, Meng Sun, et al.. (2024). Bilirubin ameliorates osteoarthritis via activating Nrf2/HO‐1 pathway and suppressing NF‐κB signalling. Journal of Cellular and Molecular Medicine. 28(7). e18173–e18173. 20 indexed citations
8.
Wang, Luhui, Haiyan Zhu, Zhehao Shi, et al.. (2023). MK8722 initiates early-stage autophagy while inhibiting late-stage autophagy via FASN-dependent reprogramming of lipid metabolism. Theranostics. 14(1). 75–95. 14 indexed citations
9.
Li, Wenjun, et al.. (2022). Cynaropicrin inhibits lung cancer proliferation by targeting EGFR/AKT signaling pathway. Tropical Journal of Pharmaceutical Research. 20(4). 715–720. 3 indexed citations
10.
Huang, Huirong, et al.. (2022). Recombinant protein drugs-based intra articular drug delivery systems for osteoarthritis therapy. European Journal of Pharmaceutics and Biopharmaceutics. 183. 33–46. 10 indexed citations
11.
Chen, Zhiwei, Huirong Huang, Meng Sun, et al.. (2022). Carbidopa suppresses estrogen receptor-positive breast cancer via AhR-mediated proteasomal degradation of ERα. Investigational New Drugs. 40(6). 1216–1230. 7 indexed citations
12.
Kou, Longfa, Huirong Huang, Yingying Tang, et al.. (2022). Opsonized nanoparticles target and regulate macrophage polarization for osteoarthritis therapy: A trapping strategy. Journal of Controlled Release. 347. 237–255. 80 indexed citations
13.
14.
Bao, Shihui, Hailun Zheng, Huirong Huang, et al.. (2021). Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment. Frontiers in Pharmacology. 12. 625084–625084. 42 indexed citations
15.
Kou, Longfa, et al.. (2020). The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines. Asian Journal of Pharmaceutical Sciences. 15(2). 145–157. 35 indexed citations
16.
Chen, Zhiwei, Aimin Cai, Hailun Zheng, et al.. (2020). Carbidopa suppresses prostate cancer via aryl hydrocarbon receptor-mediated ubiquitination and degradation of androgen receptor. Oncogenesis. 9(5). 49–49. 22 indexed citations
17.
Kou, Longfa, Huirong Huang, Xinyu Jiang, et al.. (2020). Endocytosis of ATB 0,+ (SLC6A14)-targeted liposomes for drug delivery and its therapeutic application for pancreatic cancer. Expert Opinion on Drug Delivery. 17(3). 395–405. 31 indexed citations
18.
Kou, Longfa, Rui Sun, Xinyu Jiang, et al.. (2020). Tumor Microenvironment-Responsive, Multistaged Liposome Induces Apoptosis and Ferroptosis by Amplifying Oxidative Stress for Enhanced Cancer Therapy. ACS Applied Materials & Interfaces. 12(27). 30031–30043. 61 indexed citations
19.
Huang, Mei‐Ling, et al.. (2019). Association between digital breast tomosynthesis and molecular subtypes of breast cancer. Oncology Letters. 17(3). 2669–2676. 7 indexed citations
20.
Wang, Lei, Da‐Peng Dai, Guoxin Hu, et al.. (2015). In vitroassessment of 39CYP2C9variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates. Journal of Clinical Pharmacy and Therapeutics. 40(3). 320–327. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huiming Jiang Breakdown of academic impact, for papers by Kan Chen Breakdown of academic impact, for papers by Yingying Tan Breakdown of academic impact, for papers by Qingmin Zeng Breakdown of academic impact, for papers by Deming Xiao Breakdown of academic impact, for papers by Sheng Lü Breakdown of academic impact, for papers by Xiaochen Liu Breakdown of academic impact, for papers by Sheji Weng
Rankless by CCL
2026